Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tunstall Health A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2%   Bankruptcy risk   13.0% 13.2% 28.9% 8.8% 3.7% 16.7% 19.5% 17.2%   Credit score (0-100)   20 19 2 29 51 9 6 8   Credit rating   BB BB B BB BBB BB B BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -1,363 -2,765 -4,209 2,767 6,879 71.0 0.0 0.0   EBITDA   -7,962 -7,766 -8,355 -4,188 3,968 47.0 0.0 0.0   EBIT   -9,627 -10,838 -8,710 -5,087 3,205 -417 0.0 0.0   Pre-tax profit (PTP)   -9,753.0 -10,863.0 -8,732.0 -5,352.0 2,415.0 -790.0 0.0 0.0   Net earnings   -7,620.0 -8,474.0 -7,721.0 -4,209.0 2,415.0 -588.0 0.0 0.0   Pre-tax profit without non-rec. items   -9,753 -10,863 -8,732 -5,352 2,415 -790 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Tangible assets total   598 302 121 142 68.0 0.0 0.0 0.0   Shareholders equity total   3,978 1,003 -344 -4,554 -2,139 -2,727 -5,227 -5,227   Interest-bearing liabilities   839 1,832 858 8,276 4,793 6,098 5,227 5,227   Balance sheet total (assets)   12,834 4,784 2,908 5,710 3,936 3,496 0.0 0.0   Net Debt   836 1,831 858 6,620 2,212 3,080 5,227 5,227     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -1,363 -2,765 -4,209 2,767 6,879 71.0 0.0 0.0   Gross profit growth   0.0% -102.9% -52.2% 0.0% 148.6% -99.0% -100.0% 0.0%   Employees   12 11 12 10 4 0 0 0   Employee growth %   0.0% -8.3% 9.1% -16.7% -60.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,834 4,784 2,908 5,710 3,936 3,496 0 0   Balance sheet change%   0.0% -62.7% -39.2% 96.4% -31.1% -11.2% -100.0% 0.0%   Added value   -7,962.0 -7,766.0 -8,355.0 -4,188.0 4,104.0 47.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   158 -4,513 1,185 -1,594 -1,526 -928 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   706.3% 392.0% 206.9% -183.8% 46.6% -587.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -75.0% -123.0% -216.7% -75.2% 39.2% -6.8% 0.0% 0.0%   ROI %   -199.9% -283.2% -471.5% -111.2% 49.0% -7.7% 0.0% 0.0%   ROE %   -191.6% -340.3% -394.8% -97.7% 50.1% -15.8% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Equity ratio %   32.4% 23.8% -12.8% -47.0% -35.5% -43.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -10.5% -23.6% -10.3% -158.1% 55.7% 6,553.2% 0.0% 0.0%   Gearing %   21.1% 182.7% -249.4% -181.7% -224.1% -223.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   30.0% 1.9% 1.9% 6.0% 12.1% 6.8% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Quick Ratio   1.3 1.4 0.4 0.5 0.6 0.6 0.0 0.0   Current Ratio   1.2 1.2 0.3 0.4 0.6 0.6 0.0 0.0   Cash and cash equivalent   3.0 1.0 0.0 1,656.0 2,581.0 3,018.0 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,115.0 581.0 -2,306.0 -5,794.0 -2,616.0 -2,727.0 -2,613.5 -2,613.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -664 -706 -696 -419 1,026 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -664 -706 -696 -419 992 0 0 0   EBIT / employee   -802 -985 -726 -509 801 0 0 0   Net earnings / employee   -635 -770 -643 -421 604 0 0 0